Freeline Therapeutics Holdings plc ADR buy Wedbush
Start price
04.10.23
/
50%
€3.21
Target price
04.10.24
€7.61
Performance (%)
0.00%
End price
05.10.24
-
Summary
This prediction is currently being closed. The BUY prediction by Wedbush is currently unchanged from the start price. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Freeline Therapeutics Holdings plc ADR | - | - | - |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
Comments by Wedbush for this prediction
In the thread Freeline Therapeutics Holdings plc ADR diskutieren
Freeline Therapeutics Holdings plc (NASDAQ: FRLN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock, up previously from $5.00.
Ratings data for FRLN provided by MarketBeat
In the thread Trading Freeline Therapeutics Holdings plc ADR
Die von Wedbush gewählte maximale Laufzeit wurde überschritten